Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women

Gynecologic and Obstetric Investigation

Volumn 74, Issue 2, 2012, Pages 143-150

  Seo, Seok Kyo ^a,c   Yang, Hyo In ^a,c   Lim, Kyung Jin ^a,c   Jeon, Young Eun ^b,c   Choi, Young Sik ^a,c   Cho, Sihyun ^b,c   Lee, Byung Seok ^b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Institute of Women's Life Medical Science   (South Korea)

Author keywords

Alendronate; Cartilage oligomeric matrix protein; Estrogen; Menopause; Osteoarthritis

Indexed keywords

ALENDRONIC ACID; CARTILAGE OLIGOMERIC MATRIX PROTEIN; DROSPIRENONE PLUS ESTRADIOL; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OSTEOPENIA; OUTCOME ASSESSMENT; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION;

AGED; ALENDRONATE; ANDROSTENES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CARTILAGE; ESTRADIOL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; OSTEOARTHRITIS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE;

EID: 84865841003     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000339934     Document Type: Article

References (44)

1. Wright NC, Riggs GK, Lisse JR, Chen Z: Self-reported osteoarthritis, ethnicity, body mass index, and other associated risk factors in postmenopausal women-results from the Women's Health Initiative. J Am Geriatr Soc 2008;56: 1736-1743.
2. Ministry of Health and Welfare: 2005 National Health and Nutrition Examination Survey-Summary. Seoul, Ministry of Health and Welfare, 2006.
3. Carbone LD, Nevitt MC, Wildy K, et al: The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004;50: 3516-3525.
4. Hayami T, Pickarski M, Wesolowski GA, et al: The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004;50:1193-1206.
5. Karsdal MA, Leeming DJ, Dam EB, et al: Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoar-thritis Car ti lage 2008;16: 638-646.
6. Kadri A, Funck-Brentano T, Lin H, et al: Inhibition of bone resorption blunts osteoar-thritis in mice with high bone remodelling. Ann Rheum Dis 2010;69:1533-1538.
7. Oliveria SA, Felson DT, Klein RA, Reed JI, Walker AM: Estrogen replacement therapy and the development of osteoarthritis. Epidemiology 1996;7: 415-419.
8. Nevitt MC, Cummings SR, Lane NE, et al: Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1996;156:2073-2080.
9. Spector TD, Nandra D, Hart DJ, Doyle DV: Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 1997;56: 432-434.
10. Hoegh-Andersen P, Tanko LB, Andersen TL, et al: Ovariectomized rats as a model of post-menopausal osteoarthritis: validation and application. Ar thritis Res Ther 20 04;6:R169-R180.
11. Oestergaard S, Sondergaard BC, Hoegh-An-dersen P, et al: Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Art hritis R heum 2006;54: 2441-2451.
12. Olson EJ, Lindgren BR, Carlson CS: Effects of long-term estrogen replacement therapy on the prevalence and area of periarticular tibial osteophytes in surgically postmeno-pausal cynomolgus monkeys. Bone 2007;41: 282-289.
13. Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF: Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondro-cyte synthesis of proteoglycans and insulinlike growth factor binding protein 2. Arthritis Rheum 2000;43:2081-2090.
14. Sniekers YH, Weinans H, van Osch GJ, van Leeuwen JP: Estrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis. Arthritis Res Ther 2010;12:R182.
15. Sowers MR, McConnell D, Jannausch M, Buyuktur AG, Hochberg M, Jamadar DA: Estradiol and its metabolites and their association with knee osteoarthritis. Arthritis R heum 2006;54: 2481-2487.
16. Zhang Y, McAlindon TE, Hannan MT, et al: Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998;41:1867-1873.
17. Bingham CO 3rd, Buckland-Wright JC, Garnero P, et al: Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis R heum 20 06;54: 3494-3507.
18. Strassle BW, Mark L, Leventhal L, et al: Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthritis Cartilage 2010;18: 1319-1328.
19. Calvo E, Castaneda S, Largo R, Fernandez-Valle ME, Rodriguez-Salvanes F, Herrero-Beaumont G: Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage 2007;15:69-77.
20. Hecht JT, Deere M, Putnam E, et al: Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseu-doachondroplasia musculoskeletal tissues. Matrix Biol 1998;17:269-278.
21. Petersson IF, Boegard T, Svensson B, Heine-gard D, Saxne T: Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J R heumatol 1998;37: 46-50.
22. Hunter DJ, Li J, LaValley M, et al: Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther 2007;9:R108.
23. Ravn P, Warming L, Christgau S, Christiansen C: The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy. Bone 2004;35: 1216-1221.
24. Christgau S, Tanko LB, Cloos PA, et al: Suppression of elevated cartilage turnover in postmenopausal women and in ovariecto-mized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause 2004;11: 508-518.
25. 3 alone decreases markers of cartilage and bone metabolism in rheumatoid ar thritis: a randomized controlled trial (ISRCTN46523456). Arthritis Res Ther 2004;6:R457-R468.
26. Tanko LB, Sondergaard BC, Oestergaard S, Karsdal MA, Christiansen C: An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric 2008;11:4-16.
27. Richette P, Dumontier MF, Tahiri K, et al: Oestrogens inhibit interleukin 1beta-medi-ated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment. Ann Rheum Dis 2007;66:345-350.
28. Sowers MF, Karvonen-Gutierrez CA, Yosef M, et al: Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage 2009;17:1609-1614.
29. Hanna FS, Teichtahl AJ, Wluka AE, et al: Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: a gender study of adults without clinical knee osteoarthritis. Menopause 2009;16:666-670.
30. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G: A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005;13: 769-781.
31. Neidhart M, Hauser N, Paulsson M, DiCe-sare PE, Michel BA, Hauselmann HJ: Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151-1160.
32. Dragomir AD, Kraus VB, Renner JB, et al: Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 2003;10:687-691.
33. Posey KL, Hecht JT: The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets 2008;9: 869-877.
34. Vilim V, Olejarova M, Machacek S, Gattero-va J, Kraus VB, Pavelka K: Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707-713.
35. Kumm J, Tamm A, Lintrop M: Association between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis. Calcif Tissue Int 2009;85: 514-522.
36. Eckstein F, Cicuttini F, Raynauld JP, Waterton JC, Peterfy C: Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006; 14 (suppl A):A46-A75.
37. Cranney A, Wells G, Willan A, et al: Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 20 02;23: 508-516.
38. Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C: Effect of bisphos-phonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 2002;61: 530-533.
39. Buckland-Wright JC, Messent EA, Bingham CO 3rd, Ward RJ, Tonkin C: A 2 year longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthrit-ic knee patients. Rheumatology (Oxford) 2007;46:257-264.
40. Ding M, Danielsen CC, Hvid I: The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcif Tissue Int 2008;82: 77-86.
41. Nishitani K, Shirai T, Kobayashi M, et al: Positive effect of alendronate on subchon-dral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model. Am J Sports Med 2009; 37(suppl 1):139S-147S.
42. Ivaska KK, Hentunen TA, Vaaraniemi J, Ylipahkala H, Pettersson K, Vaananen HK: Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004;279: 18361-18369.
43. Couchourel D, Aubry I, Delalandre A, et al: Altered mineralization of human osteoar-thritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009;60:1438-1450.
44. Sanchez C, Deberg MA, Bellahcnee A, et al: Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008;58: 442-455.